$MKSI

Lee John Tseng-Chung sold $3.2M of MKSI

Lee John Tseng-Chung (President & CEO) sold 10,000 shares of MKS INC (MKSI) at $315.48 ($3.15M total) on 2026-05-22 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Lee John Tseng-Chung
Published May 26, 2026, 6:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI May 26, 2026, 6:25 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$MKSI
Neutral
medium confidence
Mentioned
$MKSI
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$MKSINeutralLow
01

Why it matters

This type of disclosure is typically used for monitoring insider activity rather than forecasting earnings or operational changes.

02

Market read

Traders may briefly reassess sentiment around MKSI due to CEO selling, but the 10b5-1 plan suggests routine execution.

03

What to watch

The article provides only the sale details; without context on total planned sales, option exercises, or subsequent buys, directional inference is weak.

Relevance 6/10Timing: Immediate disclosure date (filed 2026-05-26) may cause brief, headline-driven volatility.

Background

The article is an SEC Form 4 insider transaction disclosure for MKS Inc, showing an officer/director sale executed under a pre-arranged 10b5-1 plan.

Company-level read

Ticker impact

$MKSINeutralMedium confidence
Context

MKS Inc CEO sold $3.15M of MKSI shares in an open-market transaction under a pre-arranged 10b5-1 plan.

Expected impact

Likely limited near-term impact; any reaction may fade unless accompanied by other fundamentals/news.

Evidence & confidence

The filing is a Form 4 for an officer/director sale with a stated pre-arranged 10b5-1 plan, which is often routine and not necessarily bearish.

Market effects

Minimal; this is company-specific insider liquidity rather than a sector catalyst.

Minimal; no geographic or macro linkage beyond US-listed issuer.

Minimal; no international transaction or regulatory development mentioned.

Counterpoint

Even with 10b5-1, repeated or large CEO sales can be interpreted as reduced confidence by some traders.

Key entities

  • MKS Inc

    Subject of the Form 4 insider sale by its President & CEO, Lee John Tseng-Chung.

  • Lee John Tseng-Chung

    President & CEO who sold 10,000 MKSI shares for ~$3.15M under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$TTMIHighAI 8/10

TTM Technologies Bets Big on AI, Defense Growth

TTM Technologies (TTMI) announced over $1 billion in investments, including a $650 million acquisition of MKS Inc.'s Ophir Optics unit and a $400 million expansion in China and Malaysia. The company reported strong Q3 earnings but saw a 29% share drop due to debt concerns. TTM's growth is driven by AI and defense demand, with shares up 77% over 12 months.

$MKSIHighAI 9/10

US defence group TTM Technologies to acquire Romanian optics factory as part of USD 650 million deal

TTM Technologies (TTMI) will acquire MKS Inc.'s Ophir Optics for $650M, including facilities in Romania and Israel. The deal, expected to close in Q2 2027, expands TTM's optical solutions for defense and industrial uses. TTM plans to finance the acquisition with cash, future cash flow, and borrowings. MKS aims to reduce debt and focus on core businesses.

$TTMIHighAI 9/10

TTM Technologies, Inc. has entered into a definitive agreement to acquire Ophir Optics business from MKS Inc. for $650 million.

TTM Technologies (TTMI) agreed to acquire Ophir Optics from MKS Inc. (MKSI) for $650M, payable in cash. The deal, expected to close in Q2 2027, is valued at 18x the target's 2026 EBITDA. TTM plans to fund the acquisition through cash, future cash flow, and borrowings. The transaction is expected to be immediately accretive to TTM's EBITDA margin and non-GAAP EPS.